CN117100756A - 叶绿酸组合物和其用途 - Google Patents

叶绿酸组合物和其用途 Download PDF

Info

Publication number
CN117100756A
CN117100756A CN202311249309.XA CN202311249309A CN117100756A CN 117100756 A CN117100756 A CN 117100756A CN 202311249309 A CN202311249309 A CN 202311249309A CN 117100756 A CN117100756 A CN 117100756A
Authority
CN
China
Prior art keywords
chlorophyllin
composition
compositions
ingredients
sodium copper
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202311249309.XA
Other languages
English (en)
Chinese (zh)
Inventor
C·V·萨万基卡尔
V·A·萨万基卡尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN117100756A publication Critical patent/CN117100756A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN202311249309.XA 2015-01-19 2016-01-15 叶绿酸组合物和其用途 Pending CN117100756A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN178MU2015 2015-01-19
IN178/MUM/2015 2015-01-19
PCT/IN2016/050017 WO2016116950A2 (en) 2015-01-19 2016-01-15 Chlorophyll composition
CN201680006322.4A CN107427417A (zh) 2015-01-19 2016-01-15 叶绿素组合物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201680006322.4A Division CN107427417A (zh) 2015-01-19 2016-01-15 叶绿素组合物

Publications (1)

Publication Number Publication Date
CN117100756A true CN117100756A (zh) 2023-11-24

Family

ID=56417899

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202311249309.XA Pending CN117100756A (zh) 2015-01-19 2016-01-15 叶绿酸组合物和其用途
CN201680006322.4A Pending CN107427417A (zh) 2015-01-19 2016-01-15 叶绿素组合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201680006322.4A Pending CN107427417A (zh) 2015-01-19 2016-01-15 叶绿素组合物

Country Status (10)

Country Link
US (2) US12194052B2 (https=)
EP (1) EP3247323B1 (https=)
JP (3) JP6772151B2 (https=)
CN (2) CN117100756A (https=)
AU (1) AU2016210540B2 (https=)
BR (1) BR112017015338A2 (https=)
EA (1) EA201791319A1 (https=)
ES (1) ES2879996T3 (https=)
SG (1) SG11201705694VA (https=)
WO (1) WO2016116950A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117100756A (zh) * 2015-01-19 2023-11-24 C·V·萨万基卡尔 叶绿酸组合物和其用途
EP4059493A1 (en) * 2021-03-16 2022-09-21 The Secretary, Department Of Atomic Energy A chlorophyllin containing pharmaceutical composition for prevention of pathogenesis of coronavirus disease
WO2025203055A1 (en) * 2024-03-26 2025-10-02 Council Of Scientific And Industrial Research Encapsulated dihydrofolate formulation for dietary supplementation as effective nutraceutical supplement and method of preparation thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11269073A (ja) * 1998-03-18 1999-10-05 Naigai Yakuhin Shokai:Kk 銅クロロフィリンの塩を含有してなる製剤

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2729586A (en) 1952-02-01 1956-01-03 Rystan Company Therapeutic compositions comprising water - soluble chlorophyll and salts of fatty acids
BE516996A (https=) 1952-02-19
JPS55161863A (en) 1979-06-06 1980-12-16 Paaku Deebisu Kk Colored gelatin capsule
DE4033530A1 (de) 1990-10-22 1992-04-23 Univ Schiller Jena Kristallisationsinhibitor
JPH04327534A (ja) 1991-04-24 1992-11-17 Mitsuo Namiki 活性酸素による障害の予防及び治療剤
JPH04356420A (ja) * 1991-05-31 1992-12-10 Nisshin Flour Milling Co Ltd チアミン・コバルト・クロロフィリン錯化合物含有組成物
CN1078468C (zh) 1998-07-02 2002-01-30 许德余 叶绿素铜钠盐用于制造抗胃粘膜损伤的组合物的用途
JP3657203B2 (ja) 2000-04-21 2005-06-08 エーザイ株式会社 銅クロロフィリン塩含有液剤組成物
JP2003081741A (ja) * 2001-09-13 2003-03-19 Nikko Seiyaku Kk 皮膚外用剤
JP4068442B2 (ja) * 2001-12-03 2008-03-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 味覚改善組成物
JP4951530B2 (ja) * 2005-01-31 2012-06-13 ドン ファ ファーム カンパニー リミテッド 腎障害治療用薬剤組成と薬草抽出物含有の健康食品
US7887848B2 (en) * 2006-05-31 2011-02-15 Interhealth Nutraceuticals, Inc. Nutraceutical treatments for diabetic and non-diabetic wound healing
US7947827B2 (en) * 2006-06-30 2011-05-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Pharmaceutical formulation comprising a metaloporphyrin and method for its purification and use
CA2691691C (en) * 2007-06-20 2013-09-24 Seth J. Baum Compositions and methods of treating chronic kidney disease
JP2009256228A (ja) * 2008-04-15 2009-11-05 Lion Corp 液体口腔用組成物
CN102462671A (zh) 2010-11-18 2012-05-23 何国增 叶绿素铜钠胶囊的制备方法
CN102138919A (zh) 2011-01-28 2011-08-03 武汉联合药业有限责任公司 铁叶绿酸钠用于促进红细胞生成的新用途
CN103027873A (zh) 2011-10-10 2013-04-10 马美琳 一种消炎止血牙膏
CN103285097B (zh) 2012-02-22 2014-12-10 西安世纪盛康药业有限公司 肾康注射液在制备防治放疗或化疗所致肾毒性药物中的应用
US20150352189A1 (en) * 2013-01-08 2015-12-10 Jerome Schentag Activation of the endogenous ileal brake hormone pathway for organ regeneration and related compositions, methods of treatment, diagnostics, and regulatory systems
CN117100756A (zh) * 2015-01-19 2023-11-24 C·V·萨万基卡尔 叶绿酸组合物和其用途

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11269073A (ja) * 1998-03-18 1999-10-05 Naigai Yakuhin Shokai:Kk 銅クロロフィリンの塩を含有してなる製剤

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
《中国丝绸年鉴》编辑部: "《中国丝绸年鉴》", 30 June 2001, 丝绸杂志社, pages: 161 - 162 *
国家食品药品监督管理局执业药师资格认证中心: "《药学综合知识与技能》", 31 January 2014, 中国医药科技出版社, pages: 72 - 73 *

Also Published As

Publication number Publication date
JP2021006555A (ja) 2021-01-21
EP3247323A2 (en) 2017-11-29
WO2016116950A3 (en) 2016-10-13
US20250090546A1 (en) 2025-03-20
AU2016210540A1 (en) 2017-08-10
US12194052B2 (en) 2025-01-14
SG11201705694VA (en) 2017-08-30
BR112017015338A2 (pt) 2018-01-09
WO2016116950A2 (en) 2016-07-28
EP3247323B1 (en) 2021-03-03
JP2018502893A (ja) 2018-02-01
ES2879996T3 (es) 2021-11-23
EA201791319A1 (ru) 2018-01-31
EP3247323A4 (en) 2018-07-11
US20180325915A1 (en) 2018-11-15
WO2016116950A4 (en) 2016-12-01
JP2025066799A (ja) 2025-04-23
CN107427417A (zh) 2017-12-01
JP6772151B2 (ja) 2020-10-21
AU2016210540B2 (en) 2018-10-11

Similar Documents

Publication Publication Date Title
Eliseeva et al. Vitamin C (ascorbic acid)–description, benefits and where it is found
JP2012527450A (ja) 緑茶抽出物を含有する組成物
US20250090546A1 (en) Chlorophyll composition
US5730987A (en) Medication for impotence containing lyophilized roe and a powdered extract of Ginkgo biloba
CA2234954A1 (en) Multiple vitamin supplement composition
FR2981545A1 (fr) Produit dietetique destine a la diminution de la graisse viscerale en preoperatoire bariatrique
WO2003053454A1 (en) Compositions incorporating (-)-hydroxycitric acid, chromium, and gymnemic acid, and related methods for promoting healthy body weight and improving related health factors
US20060210650A1 (en) Supplemental dietary composition for promoting weight loss
US20080268039A1 (en) Loquat compositions
JP2011195530A (ja) タンパク質糖化抑制剤
JP2010159283A (ja) プロアントシアニジン含有組成物
EP4181693A1 (en) Nutritional supplement, suitable for oral administration, comprising dihydromyricetin, choline and one or more vitamins with antioxidant activity, for use in the maintenance of normal liver function
KR102849917B1 (ko) 베프로시드를 함유하는 골관절염 개선용 조성물
FI121915B (fi) Koostumus psoriasiksen hoitoon
WO2018142328A1 (en) Composition for hyperuricemia treatment
Rashid et al. Comparative efficacy of different antidotes against experimental nitrate intoxication in rabbits
JP2005060338A (ja) プロアントシアニジン含有組成物
RU2152221C1 (ru) Средство, обладающее гепатопротекторным, холестерино- и сахарорегулирующим действием
JP4610730B2 (ja) カルシウム補給用の組成物
EA048916B1 (ru) Применение хлорофиллина для лечения заболеваний почек, терапевтические композиции хлорофиллина и способ лечения
JP2021038155A (ja) 更年期症状改善剤
JP2006083106A (ja) 血中中性脂肪濃度上昇抑制作用を有する薬剤及び飲食物
Govindan et al. Impact of Vitamins and Minerals Enriched Flora in the Management of Calciphytoliths: A Special Focus on Vitamin E
Fraser et al. Review of complimentary therapies for common ocular disorders
WO2008150197A1 (ru) Биологически активная добавка для профилактики и лечения астмы и заболеваний верхних дыхательных путей и способ ее получения

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination